Compare Novartis AG (NVS) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs TransMedics Group Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Novartis AG is far larger — about 114.3× TransMedics Group Inc's market cap, and Novartis AG pays a 3.17% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| NVS | TMDX | |
|---|---|---|
Market Cap | $290.25B | $2.54B |
Sector | Health | Technology |
52-Week High | $168.62 | $150.42 |
52-Week Low | $113.50 | $61.99 |
Enterprise Value | $330.27B | $2.94B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
